Short-Term Esmolol Improves Coronary Artery Remodeling in Spontaneously Hypertensive Rats through Increased Nitric Oxide Bioavailability and Superoxide Dismutase Activity

被引:15
作者
Arnalich-Montiel, Ana [1 ]
Carmen Gonzalez, Maria [2 ]
Delgado-Baeza, Emilio [3 ]
Jesus Delgado-Martos, Maria [3 ]
Condezo-Hoyos, Luis [2 ]
Martos-Rodriguez, Antonia [3 ]
Rodriguez-Rodriguez, Pilar [2 ]
Quintana-Villamandos, Begona [1 ,4 ]
机构
[1] Gregorio Maranon Univ Gen Hosp, Dept Anesthesiol Reanimat & Intens Care, Madrid 28007, Spain
[2] Univ Autonoma Madrid, Fac Med, Dept Physiol, E-28029 Madrid, Spain
[3] Gregorio Maranon Univ Gen Hosp, Dept Expt Med & Surg, Madrid 28007, Spain
[4] Univ Complutense, Fac Med, Dept Pharmacol, E-28040 Madrid, Spain
关键词
BETA-ADRENERGIC BLOCKER; BLOOD-PRESSURE; ARRHYTHMIAS; NITRATE; HEART; ANION;
D O I
10.1155/2014/531087
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 090105 [作物生产系统与生态工程];
摘要
The aim of this study was to assess the effects of short-term esmolol therapy on coronary artery structure and function and plasma oxidative stress in spontaneously hypertensive rats (SHR). For this purpose, 14-month-old male SHR were treated for 48 hours with esmolol (SHR-E, 300 mu g/kg/min). Age-matched untreated male SHR and Wistar Kyoto rats (WKY) were used as hypertensive and normotensive controls, respectively. At the end of intervention we performed a histological study to analyze coronary artery wall width (WW), wall-to-lumen ratio (W/L), and media cross-sectional area (MCSA). Dose-response curves for acetylcholine (ACh) and sodium nitroprusside were constructed. We also assessed several plasma oxidative stress biomarkers, namely, superoxide scavenging activity (SOSA), nitrites, and total antioxidant capacity (TAC). We observed a significant reduction in WW (P < 0.001), W/L (P < 0.05), and MCSA (P < 0.01) and improved endothelium-dependent relaxation (AUC(SHR-E) = 201.2 +/- 33 versus AUC(SHR) = 97.5 +/- 21, P < 0.05) in SHR-E compared with untreated SHR; no differences were observed for WW, MCSA, and endothelium-dependent relaxation by ACh at higher concentrations (10(-6) to 10(-4) mol/l) for SHR-E with respect to WKY. SOSA (P < 0.001) and nitrite (P < 0.01) values were significantly higher in SHR-E than in untreated SHR; however, TAC did not increase after treatment with esmolol. Esmolol improves early coronary artery remodeling in SHR.
引用
收藏
页数:9
相关论文
共 37 条
[1]
Regression of Small Resistance Artery Structural Alterations in Hypertension by Appropriate Antihypertensive Treatment [J].
Agabiti-Rosei, Enrico ;
Rizzoni, Damiano .
CURRENT HYPERTENSION REPORTS, 2010, 12 (02) :80-85
[2]
Amaral SL, 2011, BRAZ J MED BIOL RES, V44, P814, DOI 10.1590/S0100-879X2011000900001
[3]
Carvedilol prevents severe hypertensive cardiomyopathy and remodeling [J].
Barone, FC ;
Campbell, WG ;
Nelson, AH ;
Feuerstein, GZ .
JOURNAL OF HYPERTENSION, 1998, 16 (06) :871-884
[4]
L-Arginine Fails to Prevent Ventricular Remodeling and Heart Failure in the Spontaneously Hypertensive Rat [J].
Brooks, Wesley W. ;
Conrad, Chester H. ;
Robinson, Kathleen G. ;
Colucci, Wilson S. ;
Bing, Oscar H. L. .
AMERICAN JOURNAL OF HYPERTENSION, 2009, 22 (02) :228-234
[5]
Age-dependent ultrastructural changes of coronary artery in spontaneously hypertensive rats [J].
Cebova, Martina ;
Kristek, Frantisek .
GENERAL PHYSIOLOGY AND BIOPHYSICS, 2011, 30 (04) :364-372
[6]
Superoxide anion and K+ channels mediate electrical stimulation-induced relaxation in the rat basilar artery [J].
Conde, MV ;
Marín, J ;
Balfagón, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 372 (02) :179-186
[7]
BETA-RECEPTOR ANTAGONISM DOES NOT FULLY EXPLAIN ESMOLOL-INDUCED HYPOTENSION [J].
DEEGAN, R ;
WOOD, AJJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 56 (02) :223-228
[8]
Hypertension and microvascular remodelling [J].
Feihl, Francois ;
Liaudet, Lucas ;
Levy, Bernard I. ;
Waeber, Bernard .
CARDIOVASCULAR RESEARCH, 2008, 78 (02) :274-285
[9]
Fita G., 1999, REV ESP ANESTESIOL R, V46, P401
[10]
Risk factor-induced cardiovascular remodeling and the effects of angiotensin-converting enzyme inhibitors [J].
Galderisi, Maurizio ;
de Divittis, Oreste .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2008, 51 (06) :523-531